Current Drug Targets


Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Editorial (Hot Topic:Sirtuins as Drug Targets) promotion: free to download

Volume:14   Issue: 6
Pp: 621-621
Camillo Rosano
DOI: 10.2174/1389450111314060001
Published on: 30 April, 2013

Sirtuins as Possible Drug Targets in Type 2 Diabetes

Volume:14   Issue: 6
Pp: 622-636
Munehiro Kitada, Shinji Kume, Keizo Kanasaki, Ai Takeda-Watanabe and Daisuke Koya
DOI: 10.2174/1389450111314060002
Published on: 30 April, 2013

Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Therapeutics: Rationales, Controversies, Clinical Experience

Volume:14   Issue: 6
Pp: 637-643
By Fabrizio Montecucco, Michele Cea, Inga Bauer, Debora Soncini, Irene Caffa, Denise Lasiglie, Aimable Nahimana, Antonio Uccelli, Santina Bruzzone and Alessio Nencioni
DOI: 10.2174/1389450111314060003
Published on: 30 April, 2013

Sirtuins as Possible Targets in Neurodegenerative Diseases

Volume:14   Issue: 6
Pp: 644-647
Gizem Donmez
DOI: 10.2174/1389450111314060004
Published on: 30 April, 2013

Sirtuin-1 and HIV-1: An Overview

Volume:14   Issue: 6
Pp: 648-652
Marilia Rita Pinzone, Bruno Cacopardo, Fabrizio Condorelli, Michele Di Rosa and Giuseppe Nunnari
DOI: 10.2174/1389450111314060005
Published on: 30 April, 2013

Human Sirtuins: An Overview of an Emerging Drug Target in Age-Related Diseases and Cancer

Volume:14   Issue: 6
Pp: 653-661
Alessandra Donadini, Camillo Rosano, Lamberto Felli and Marco Ponassi
DOI: 10.2174/1389450111314060006
Published on: 30 April, 2013

Structure and Evolution of Human Sirtuins

Volume:14   Issue: 6
Pp: 662-665
Domenico Bordo
DOI: 10.2174/1389450111314060007
Published on: 30 April, 2013

Sirtuins Family- Recent Development as a Drug Target for Aging, Metabolism, and Age Related Diseases

Volume:14   Issue: 6
Pp: 666-675
Chiranjib Chakraborty and George Priya Doss. C
DOI: 10.2174/1389450111314060008
Published on: 30 April, 2013

Key Targets and Relevant Inhibitors for the Drug Discovery of Tuberculosis

Volume:14   Issue: 6
Pp: 676-699
Xiuming Xiong, Zhijian Xu, Zhuo Yang, Yingtao Liu, Di Wang, Mei Dong, Emily J. Parker and Weiliang Zhu
DOI: 10.2174/1389450111314060009
Published on: 30 April, 2013

Hypoxia-Inducible Factor: A Potential Therapeutic Target for Rheumatoid Arthritis

Volume:14   Issue: 6
Pp: 700-707
Xuli Zhao, Ye Yue, Wengxiang Cheng, Jingchao Li, Yiping Hu, Ling qin and Peng Zhang
DOI: 10.2174/1389450111314060010
Published on: 30 April, 2013

Omega – 3 Fatty Acids as Pharmacotherapeutics in Psoriasis: Current Status and Scope of Nanomedicine in its Effective Delivery

Volume:14   Issue: 6
Pp: 708-722
Mahfoozur Rahman, Sarwar Beg, Mohammad Zaki Ahmad, Imran Kazmi, Aziz Ahmed, Ziyaur Rahman, Farhan Jalees Ahmad and Sohail Akhter
DOI: 10.2174/1389450111314060011
Published on: 30 April, 2013